|
1
|
Lacolley P, Regnault V, Nicoletti A, Li Z
and Michel JB: The vascular smooth muscle cell in arterial
pathology: A cell that can take on multiple roles. Cardiovasc Res.
95:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Q, Zhang H, Liu Y, Adams S, Eilken H,
Stehling M, Corada M, Dejana E, Zhou B and Adams RH: Endothelial
cells are progenitors of cardiac pericytes and vascular smooth
muscle cells. Nat Commun. 7:124222016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Régent A, Ly KH, Lofek S, Clary G, Tamby
M, Tamas N, Federici C, Broussard C, Chafey P, Liaudet-Coopman E,
et al: Proteomic analysis of vascular smooth muscle cells in
physiological condition and in pulmonary arterial hypertension:
Toward contractile versus synthetic phenotypes. Proteomics.
16:2637–2649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
In This Issue. Proc Natl Acad Sci.
104:7731–7732. 2007.doi: 10.1073/iti1907104. View Article : Google Scholar
|
|
6
|
Kato Y, Yokoyama U, Fujita T, Umemura M,
Kubota T and Ishikawa Y: Epac1 deficiency inhibits basic fibroblast
growth factor-mediated vascular smooth muscle cell migration. J
Physiol Sci. 69:175–184. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim SH, Yun SJ, Kim YH, Ha JM, Jin SY, Lee
HS, Kim SJ, Shin HK, Chung SW and Bae SS: Essential role of
krüppel-like factor 5 during tumor necrosis factor α-induced
phenotypic conversion of vascular smooth muscle cells. Biochem
Biophys Res Commun. 463:1323–1327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shawky NM and Segar L: Sulforaphane
inhibits platelet-derived growth factor-induced vascular smooth
muscle cell proliferation by targeting mTOR/p70S6kinase signaling
independent of Nrf2 activation. Pharmacol Res. 119:251–264. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiang R, Chen J, Li S, Yan H, Meng Y, Cai
J, Cui Q, Yang Y, Xu M, Geng B and Yang J: VSMC-specific deletion
of FAM3A attenuated ang ii-promoted hypertension and cardiovascular
hypertrophy. Circ Res. 126:1746–1759. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong S, Xiong W, Yuan J, Li J, Liu J and
Xu X: MiRNA-146a regulates the maturation and differentiation of
vascular smooth muscle cells by targeting NF-κB expression. Mol Med
Rep. 8:407–412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frismantiene A, Philippova M, Erne P and
Resink TJ: Smooth muscle cell-driven vascular diseases and
molecular mechanisms of VSMC plasticity. Cell Signal. 52:48–64.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Zhang L, Wang Y, Ding H, Xue S,
Qi H and Li P: MicroRNAs or long noncoding RNAs in diagnosis and
prognosis of coronary artery disease. Aging Dis. 10:353–366. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cai W, Zhang J and Yang J, Fan Z, Liu X,
Gao W, Zeng P, Xiong M, Ma C and Yang J: MicroRNA-24 attenuates
vascular remodeling in diabetic rats through PI3K/Akt signaling
pathway. Nutr Metab Cardiovasc Dis. 29:621–632. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao F, Kataoka M, Liu N, Liang T, Huang
ZP, Gu F, Ding J, Liu J, Zhang F, Ma Q, et al: Therapeutic role of
miR-19a/19b in cardiac regeneration and protection from myocardial
infarction. Nat Commun. 10:18022019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu WH, Hu CP, Chen XP, Zhang WF, Li XW,
Xiong XM and Li YJ: MicroRNA-130a mediates proliferation of
vascular smooth muscle cells in hypertension. Am J Hypertens.
24:1087–1093. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gareri C, Iaconetti C, Sorrentino S,
Covello C, De Rosa S and Indolfi C: miR-125a-5p modulates
phenotypic switch of vascular smooth muscle cells by targeting
ETS-1. J Mol Biol. 429:1817–1828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goettsch C: miRNA-125b and their targets
in cardiovascular calcification. Proc Physiol Soc. 13:1234–1246.
2013.
|
|
18
|
Fan X, Liu M, Tang H, Leng D, Hu S, Lu R,
Wan W and Yuan S: MicroRNA-7 exerts antiangiogenic effect on
colorectal cancer via ERK signaling. J Surg Res. 240:48–59. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yano S, Kondo K, Yamaguchi M, Richmond G,
Hutchison M, Wakeling A, Averbuch S and Wadsworth P: Distribution
and function of EGFR in human tissue and the effect of EGFR
tyrosine kinase inhibition. Anticancer Res. 23:3639–3650.
2003.PubMed/NCBI
|
|
20
|
Clauditz TS, Gontarewicz A, Lebok P,
Tsourlakis MC, Grob TJ, Münscher A, Sauter G, Bokemeyer C, Knecht R
and Wilczak W: Epidermal growth factor receptor (EGFR) in salivary
gland carcinomas: Potentials as therapeutic target. Oral Oncol.
48:991–996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee JS, Kim SY, Kwon CH and Kim YK:
EGFR-dependent ERK activation triggers hydrogen peroxide-induced
apoptosis in OK renal epithelial cells. Arch Toxicol. 80:337–346.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schreier B, Döhler M, Rabe S, Schneider B,
Schwerdt G, Ruhs S, Sibilia M, Gotthardt M, Gekle M and Grossmann
C: Consequences of epidermal growth factor receptor (ErbB1) loss
for vascular smooth muscle cells from mice with targeted deletion
of ErbB1. Arterioscler Thromb Vasc Biol. 31:1643–1652. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong X, Hu H, Fang Z, Cui J and Liu F:
CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell
proliferation and migration. Biomed Pharmacother. 103:844–850.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye G, Huang K, Yu J, Zhao L, Zhu X, Yang
Q, Li W, Jiang Y, Zhuang B, Liu H, et al: MicroRNA-647 Targets
SRF-MYH9 axis to suppress invasion and metastasis of gastric
cancer. Theranostics. 7:3338–3353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun L, Lian JX and Meng S: MiR-125a-5p
promotes osteoclastogenesis by targeting TNFRSF1B. Cell Mol Biol
Lett. 24:232019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu H, Ma Y, Liu C, Li P and Yu T: Reduced
miR-125a-5p level in non-small-cell lung cancer is associated with
tumour progression. Open Biol. 8:1801182018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vo DT, Karanam NK, Ding L, Saha D, Yordy
JS, Giri U, Heymach JV and Story MD: miR-125a-5p functions as tumor
suppressor microRNA and is a marker of locoregional recurrence and
poor prognosis in head and neck cancer. Neoplasia. 21:849–862.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, An X, Bao L, Li Y, Pan Y, He J, Liu
L, Zhu X, Zhang J, Cheng J and Chu W: MiR-125a-3p-KLF15-BCAA
regulates the skeletal muscle branched-chain amino acid metabolism
in nile tilapia (Oreochromis niloticus) during starvation.
Front Genet. 11:8522020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Che P, Liu J, Shan Z, Wu R, Yao C, Cui J,
Zhu X and Wang J, Burnett MS, Wang S and Wang J: miR-125a-5p
impairs endothelial cell angiogenesis in aging mice via RTEF-1
downregulation. Aging Cell. 13:926–934. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng X, Wu Z, Xu K, Qiu Y, Su X, Zhang Z
and Zhou M: Interfering histone deacetylase 4 inhibits the
proliferation of vascular smooth muscle cells via regulating
MEG3/miR-125a-5p/IRF1. Cell Adh Migr. 13:41–49. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang X, Qiu J, Kang H, Wang Y and Qian J:
miR-125a-5p suppresses colorectal cancer progression by targeting
VEGFA. Cancer Manag Res. 10:5839–5853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Zhang D, Lv J, Wang S and Zhang
Q: MiR-125a-5p suppresses bladder cancer progression through
targeting FUT4. Biomed Pharmacother. 108:1039–1047. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu L, Li Y, Yin L, Qi Y, Sun H, Sun P, Xu
M, Tang Z and Peng J: miR-125a-5p ameliorates hepatic glycolipid
metabolism disorder in type 2 diabetes mellitus through targeting
of STAT3. Theranostics. 8:5593–5609. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Horsham JL, Ganda C, Kalinowski FC, Brown
RA, Epis MR and Leedman PJ: MicroRNA-7: A miRNA with expanding
roles in development and disease. Int J Biochem Cell Biol.
69:215–224. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ha YM, Nam JO and Kang YJ: Pitavastatin
regulates ang II induced proliferation and migration via IGFBP-5 in
VSMC. Korean J Physiol Pharmacol. 19:499–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang BF, Jiang H, Chen J, Guo X, Hu Q and
Yang S: KDM3A inhibition attenuates high concentration
insulin-induced vascular smooth muscle cell injury by suppressing
MAPK/NF-κB pathways. Int J Mol Med. 41:1265–1274. 2018.PubMed/NCBI
|
|
38
|
Park HJ, Kim MK, Kim Y, Bae SS, Kim HJ,
Bae SK and Bae MK: Gastrin-releasing peptide promotes the migration
of vascular smooth muscle cells through upregulation of matrix
metalloproteinase-2 and −9. BMB Rep. 50:628–633. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qi S, Perrino S, Miao X, Lamarche-Vane N
and Brodt P: The chemokine CCL7 regulates invadopodia maturation
and MMP-9 mediated collagen degradation in liver-metastatic
carcinoma cells. Cancer Lett. 483:98–113. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li TJ, Jiang YM, Hu YF, Huang L, Yu J,
Zhao LY, Deng HJ, Mou TY, Liu H, Yang Y, et al:
Interleukin-17-producing neutrophils link inflammatory stimuli to
disease progression by promoting angiogenesis in gastric cancer.
Clin Cancer Res. 23:1575–1585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang P, Guan Q, Zhou D, Yu Z, Song Y and
Qiu W: miR-21 inhibitors modulate biological functions of gastric
cancer cells via PTEN/PI3K/mTOR pathway. DNA Cell Biol. 37:38–45.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schreier B, Schwerdt G, Heise C, Bethmann
D, Rabe S, Mildenberger S and Gekle M: Substance-specific
importance of EGFR for vascular smooth muscle cells motility in
primary culture. Biochim Biophys Acta. 1863:1519–1533. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Spano JP, Lagorce C, Atlan D, Milano G,
Domont J, Benamouzig R, Attar A, Benichou J, Martin A, Morere JF,
et al: Impact of EGFR expression on colorectal cancer patient
prognosis and survival. Ann Oncol. 16:102–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang
W, Di W and Qiu L: MicroRNA-7 inhibits tumor metastasis and
reverses epithelial-mesenchymal transition through AKT/ERK1/2
inactivation by targeting EGFR in epithelial ovarian cancer. PLoS
One. 9:e967182014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lin T, Ren Q, Zuo W, Jia R, Xie L, Lin R,
Zhao H, Chen J, Lei Y, Wang P, et al: Valproic acid exhibits
anti-tumor activity selectively against
EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of
ErbB family members-targeting microRNAs. J Exp Clin Cancer Res.
38:1502019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Schreier B, Gekle M and Grossmann C: Role
of epidermal growth factor receptor in vascular structure and
function. Curr Opin Nephrol Hypertens. 23:113–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
